Nevro Corp

NYSE:NVROUnited States

Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.

Contact Information

Headquarters

1800 Bridge ParkwayREDWOOD CITY, CA, United States 94065

Phone

650-251-0005

Fax

302-655-5049

Executives

Executive Chairman of the Board

D. Keith Grossman

President, Chief Executive Officer, Director

Kevin Thornal

Chief Financial Officer, Senior Vice President

Roderick Macleod

Chief Operating Officer

Christopher Christoforou

Senior Vice President, Chief Medical Officer

David Caraway